Phase 2 Study of Darbepoetin Alfa Extended Dosing

NCT00527215 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
98
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen